학술논문
Low-Dose Radiation Therapy with Nivolumab in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of the Phase II Radvax Trial
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:3726-3727
Subject
Language
ISSN
0006-4971